EU drugs agency to present the latest statistics, trends and analysis

How are countries tackling the new drugs phenomenon? Are school children consuming drugs more or less than before? How many Europeans are using cannabis on a daily basis? To what extent have national responses to the drugs problem been effective?

These are just some of the issues under the spotlight in the Annual report 2012 from the EU drugs agency (EMCDDA) to be released in Lisbon on 15 November. Launching the annual assessment of Europe’s drugs problem will be European Commissioner for Home Affairs Cecilia Malmström, Chairman of the EMCDDA Management Board João Goulão and EMCDDA Director Wolfgang Götz.

The report, the agency’s flagship publication, provides the latest data and commentary on the drug situation across the 27 EU Member States, Norway, Croatia and Turkey. Key challenges are discussed along with some of the promising practices used to address drug problems today.

The Annual report is part of a comprehensive package of information. Full details available on 15 November.

  • Launch date: Thursday 15 November 2012
  • Time: 10:00 Western European Time (Lisbon) (11:00 Central European Time)
  • Press conference venue: Conference Centre, Cais do Sodré, 1249-289, Lisbon
  • Interviews: European Commission and EMCDDA representatives will be available on the day of the launch in Lisbon to answer journalists’ questions. Across Europe, staff at the Reitox national focal points will answer country-specific queries (interview details available at above link) 
  • Social media: http://twitter.com/emcddawww.facebook.com/emcdda
  • Subscribe to our RSS newsfeed

 


News by year

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80

Maria José Louro Bailey
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 211 21 03 80